Title:
ベータ−サラセミアの処置のための方法及び医薬組成物
Document Type and Number:
Japanese Patent JP6527149
Kind Code:
B2
Abstract:
The present invention relates to methods and pharmaceutical compositions for the treatment of beta-thalassemias. In particular, the present invention relates to an XPO1 inhibitor for use in a method for treating beta-thalassemia in a subject in need thereof.
More Like This:
| WO/2003/089638 | NUCLEIC ACID MOLECULE ENCODING A VARIANT DDAH 1 PROTEIN AND USES THEREOF |
| JP2020510671 | Glycan interacting compounds and methods of use |
| JP2017530940 | PRMT5 Inhibitors and Their Use |
Inventors:
Hermine, Olivier
Guem, Flavia
Arles, Jean-Benowie
Kurtowa, Genevieve
Guem, Flavia
Arles, Jean-Benowie
Kurtowa, Genevieve
Application Number:
JP2016534904A
Publication Date:
June 05, 2019
Filing Date:
November 28, 2014
Export Citation:
Assignee:
Institut National De La Sante & De La Recherche Medical
International Classes:
A61K45/00; A61K31/4196; A61K31/422; A61K31/424; A61K31/4245; A61K31/433; A61K31/4439; A61K31/454; A61K31/496; A61K31/497; A61K31/498; A61K31/506; A61K31/53; A61K31/5377; A61K31/55; A61P7/06; A61P43/00; G01N33/15
Foreign References:
| WO2011109799A1 | ||||
| WO2012099807A1 | ||||
| WO2013020024A2 | ||||
| WO2013019548A1 | ||||
| WO2013019561A1 |
Other References:
Blood,2013年10月24日,122(17),p.3034-3044
Nature,2007年 1月 4日,445,p.102-105
The Egyptian Journal of Medical Human Genetics,2012年,13,p.245-255
J Pharm Bioallied Sci.,2012年,4(3),p.194-201
Nature,2007年 1月 4日,445,p.102-105
The Egyptian Journal of Medical Human Genetics,2012年,13,p.245-255
J Pharm Bioallied Sci.,2012年,4(3),p.194-201
Attorney, Agent or Firm:
Patent business corporation Tsukuni